Vladimir Zelenko, 48, Dies; Promoted an Unfounded Covid Treatment
A self-described “simple country doctor,” he won national attention in 2020 when the White House embraced his hydroxychloroquine regimen.
A self-described “simple country doctor,” he won national attention in 2020 when the White House embraced his hydroxychloroquine regimen.
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
His company, Emergent BioSolutions, won a lucrative contract to produce Covid vaccines but then had to throw out millions of contaminated doses.
After one of his sons fell into a deep depression, he helped him recover. He later licensed an antidepressant that was a boon to his […]
After one of his sons fell into a deep depression, he helped him recover. He later licensed an antidepressant that was a boon to his […]
After one of his sons fell into a deep depression, he helped him recover. He later licensed an antidepressant that was a boon to his […]
Mr. Hanly had been central to the current nationwide litigation against pharmaceutical companies, pharmacies and others in the opioid supply chain.
Mr. Hanly had been central to the current nationwide litigation against pharmaceutical companies, pharmacies and others in the opioid supply chain.
Mr. Hanly had been central to the current nationwide litigation against pharmaceutical companies, pharmacies and others in the opioid supply chain.
A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C.
A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C.
He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at […]
He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at […]
He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at […]
He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at […]
He was a top executive at Memorial Sloan Kettering before resigning over payments from health care companies. He went on to lead cancer research at […]
He was the first hospital official to question the use of an unregulated vitamin injection linked to the deaths of 38 infants. He died of […]
He was the first hospital official to question the use of an unregulated vitamin injection linked to the deaths of 38 infants. He died of […]
He was the first hospital official to question the use of an unregulated vitamin injection linked to the deaths of 38 infants. He died of […]
Copyright © 2024 | WordPress Theme by MH Themes